This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Frank Cutitta: Innovator in Cancer Research
Introduction
Frank Cutitta is a notable inventor based in Adamstown, MD, who has made significant contributions to the field of cancer research through his innovative work with adrenomedullin peptides. His singular patent reflects a groundbreaking approach to understanding the mechanisms of cancer proliferation and offers potential therapeutic avenues.
Latest Patents
Cutitta holds a patent focused on adrenomedullin, a peptide that proves to be expressed in various human cancer cell lines. The patent details how adrenomedullin acts as a universal autocrine growth factor, catalyzing neoplastic proliferation. Additionally, it emphasizes the development of AM peptides and antibodies, which could lead to advancements in therapeutic, pharmacologic, and physiological compositions. The patent also outlines methods for diagnosing, treating, and preventing diseases using these innovative compositions. Furthermore, it describes experimental models that clarify the role of adrenomedullin in pancreatic physiology, including insights into its effects on insulin secretion.
Career Highlights
Currently, Frank Cutitta is affiliated with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His work stands as a testament to his commitment to advancing medical science and providing solutions to complex health challenges.
Collaborations
In his journey, Cutitta has collaborated with esteemed colleagues such as Alfredo Martinez and Mae Jean Miller. These partnerships underscore the importance of teamwork in scientific innovation and enhance the depth of research in the realm of cancer therapeutics.
Conclusion
Frank Cutitta's contributions through his patent on adrenomedullin peptides have the potential to change the landscape of cancer treatment and diagnosis. His innovative spirit and dedicated collaborations with fellow researchers position him as a key figure in medical research, promising to pave the way for future discoveries in oncology.